Rifan Muazin

The Intersection of Advocacy and Survival: Alexis Fish’s Journey Through Triple-Positive Breast Cancer and the Power of Community Support

• Patient Advocacy and Support

The Intersection of Advocacy and Survival: Alexis Fish’s Journey Through Triple-Positive Breast Cancer and the Power of Community Support

Rifan Muazin June 28, 2026

LOS ANGELES, CA — As the calendar turned to June 2026, marking the beginning of Pride Month,...

Read More Read more about The Intersection of Advocacy and Survival: Alexis Fish’s Journey Through Triple-Positive Breast Cancer and the Power of Community Support

Biotech Pulse: FDA Shifts Strategy as Major Deals and Breakthroughs Reshape the Landscape

• Chemotherapy and Targeted Therapy

Biotech Pulse: FDA Shifts Strategy as Major Deals and Breakthroughs Reshape the Landscape

Rifan Muazin June 26, 2026

The pharmaceutical and biotechnology sectors are undergoing a period of intense transformation, characterized by a recalibration of...

Read More Read more about Biotech Pulse: FDA Shifts Strategy as Major Deals and Breakthroughs Reshape the Landscape

Beyond the Diagnosis: Lessons in Community Support During a Cancer Journey

• Survivorship and Post-Treatment

Beyond the Diagnosis: Lessons in Community Support During a Cancer Journey

Rifan Muazin June 25, 2026

By Editorial Staff October 6, 2025 The diagnosis of breast cancer is often described as a singular...

Read More Read more about Beyond the Diagnosis: Lessons in Community Support During a Cancer Journey

Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

• Medical Research and Clinical Trials

Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

Rifan Muazin June 25, 2026

Cambridge, MA – [Insert Date] – Ascletis Pharma Inc. has announced a significant advancement in its pursuit...

Read More Read more about Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

Breakthroughs in Precision Oncology: The Evolution of TCR-Modified Cell Therapies for Solid Tumors

• Clinical Oncology Education

Breakthroughs in Precision Oncology: The Evolution of TCR-Modified Cell Therapies for Solid Tumors

Rifan Muazin June 25, 2026

The landscape of oncology is currently undergoing a paradigm shift. For decades, the treatment of solid tumors—particularly...

Read More Read more about Breakthroughs in Precision Oncology: The Evolution of TCR-Modified Cell Therapies for Solid Tumors

A Decade of Hope: Carrying Forward the Legacy of Rochelle Shoretz and the Sharsheret Movement

• Survivorship and Post-Treatment

A Decade of Hope: Carrying Forward the Legacy of Rochelle Shoretz and the Sharsheret Movement

Rifan Muazin June 24, 2026

By Editorial Staff December 01, 2025 Ten years after the passing of its visionary founder, Rochelle Shoretz,...

Read More Read more about A Decade of Hope: Carrying Forward the Legacy of Rochelle Shoretz and the Sharsheret Movement

Prime Day 2026: The Strategic Yogi’s Guide to Elevating Your Practice for Less

• Integrative Oncology and Holistic Care

Prime Day 2026: The Strategic Yogi’s Guide to Elevating Your Practice for Less

Rifan Muazin June 23, 2026

Published: June 23, 2026 For the modern practitioner, Amazon Prime Day serves as a double-edged sword. On...

Read More Read more about Prime Day 2026: The Strategic Yogi’s Guide to Elevating Your Practice for Less

Masimo Secures FDA Clearance for AI-Powered OIRD Detection to Enhance Hospital Patient Safety

• Treatment Innovations

Masimo Secures FDA Clearance for AI-Powered OIRD Detection to Enhance Hospital Patient Safety

Rifan Muazin June 23, 2026

In a significant advancement for hospital-based patient monitoring, medical diagnostics leader Masimo has announced that it has...

Read More Read more about Masimo Secures FDA Clearance for AI-Powered OIRD Detection to Enhance Hospital Patient Safety

Beyond the Dollar: Cultivating Community and Education Through Breast Cancer Fundraising

• Patient Advocacy and Support

Beyond the Dollar: Cultivating Community and Education Through Breast Cancer Fundraising

Rifan Muazin June 23, 2026

August 20, 2025 – As Breast Cancer Awareness Month approaches, the National Breast Cancer Foundation (NBCF) is...

Read More Read more about Beyond the Dollar: Cultivating Community and Education Through Breast Cancer Fundraising

AbbVie Bolsters Immunology Dominance with $11 Billion Acquisition of Apogee Therapeutics

• Treatment Innovations

AbbVie Bolsters Immunology Dominance with $11 Billion Acquisition of Apogee Therapeutics

Rifan Muazin June 23, 2026

In a move that signals its aggressive strategy to maintain dominance in the lucrative immunology market, pharmaceutical...

Read More Read more about AbbVie Bolsters Immunology Dominance with $11 Billion Acquisition of Apogee Therapeutics